Markobenz Ventures Intrinsic Value
Markobenz Ventures (NEWTRAC) median intrinsic value is ₹3.16 from 7 valuation models (range ₹2–₹11), vs current price ₹5.25 — -39.8% downside (Trading Above Calculated Value), margin of safety -66.1%. For current market price and key ratios, visit NEWTRAC company profile.
NEWTRAC Valuation Methods Summary — DCF, Graham Number & P/E
Markobenz Ventures intrinsic value across 7 models vs current price ₹5.25 — upside/downside and value range per method. Browse NEWTRAC cash flow statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.40 | ₹1.92 - ₹2.88 | -54.3% | EPS: ₹0.20, Sector P/E: 12x |
| Book Value Method | asset | ₹5.79 | ₹5.21 - ₹6.37 | +10.3% | Book Value/Share: ₹5.79, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹10.50 | ₹9.45 - ₹11.55 | +100.0% | Revenue/Share: ₹22.63, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹3.16 | ₹2.84 - ₹3.48 | -39.8% | EBITDA: ₹1.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹1.57 | ₹1.41 - ₹1.73 | -70.1% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1.72 | ₹1.55 - ₹1.89 | -67.2% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| Graham Defensive Method | conservative | ₹5.10 | ₹4.59 - ₹5.61 | -2.9% | EPS: ₹0.20, BVPS: ₹5.79 |
NEWTRAC Intrinsic Value vs Market Price — All Valuation Models
Markobenz Ventures fair value range ₹2–₹11 vs current market price ₹5.25 across 7 valuation models. Compare with NEWTRAC fundamental valuation to assess whether the stock is under or overvalued.
NEWTRAC Intrinsic Value Analysis — Undervalued or Overvalued?
Markobenz Ventures median intrinsic value ₹3.16, current price ₹5.25 — Trading Above Calculated Value by 39.8%, margin of safety -66.1%.
What is the intrinsic value of NEWTRAC?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Markobenz Ventures (NEWTRAC) is ₹3.16 (median value). With the current market price of ₹5.25, this represents a -39.8% variance from our estimated fair value.
The valuation range spans from ₹1.57 to ₹10.50, indicating ₹1.57 - ₹10.50.
Is NEWTRAC undervalued or overvalued?
Based on our multi-method analysis, Markobenz Ventures (NEWTRAC) appears to be trading above calculated value by approximately 39.8%.
NEWTRAC Financial Health — Key Ratios vs Industry Benchmarks
Markobenz Ventures financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 2.45 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.59x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
NEWTRAC Cash Flow Quality — Operating & Free Cash Flow
Markobenz Ventures operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-16 Cr | ₹-16 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |